Yuko Fujita Selected Research

Yuko Fujita Research Topics

Disease

26	Schizophrenia (Dementia Praecox) 06/2022 - 03/2007
5	Psychotic Disorders (Schizoaffective Disorder) 06/2022 - 11/2016
5	Inflammation (Inflammations) 01/2022 - 10/2014
5	Cognitive Dysfunction 01/2020 - 06/2008
4	Osteoporosis 01/2022 - 03/2011
4	Neoplasms (Cancer) 12/2021 - 04/2016
4	Hypercholesterolemia 12/2007 - 01/2003
3	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 04/2016
3	Major Depressive Disorder (Major Depressive Disorders) 11/2017 - 09/2014
2	Body Weight (Weight, Body) 01/2022 - 01/2015
2	Postmenopausal Osteoporosis 01/2022 - 12/2020
2	Anhedonia 01/2021 - 08/2020
2	Bone Resorption 01/2020 - 12/2016
2	Alzheimer Disease (Alzheimer's Disease) 11/2010 - 08/2010
2	Type 2 Diabetes Mellitus (MODY) 03/2010 - 08/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Splenomegaly 01/2022
1	Malocclusion (Crossbite) 10/2021
1	Colitis 04/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Neuralgia (Stump Neuralgia) 12/2020
1	Pain (Aches) 12/2020
1	Carcinoma (Carcinomatosis) 05/2020
1	Ovarian Epithelial Carcinoma 05/2020
1	Stroke (Strokes) 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Autism Spectrum Disorder 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Ischemic Stroke 01/2020
1	Autistic Disorder (Autism) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Treatment-Resistant Depressive Disorder 01/2019
1	Fibrosarcoma 01/2019
1	Tardive Dyskinesia 10/2017

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 06/2022 - 08/2012
9	Ketamine FDA LinkGeneric 06/2022 - 10/2018
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 02/2008
7	Serine (L-Serine)FDA Link 01/2020 - 06/2009
6	Antidepressive Agents (Antidepressants)IBA 06/2022 - 10/2014
5	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 09/2014
5	N-Methylaspartate (NMDA)IBA 11/2016 - 02/2008
4	Epoxide HydrolasesIBA 01/2021 - 01/2004
4	Amino Acids FDA Link 01/2020 - 01/2003
4	Antipsychotic Agents (Antipsychotics)IBA 10/2017 - 08/2012
4	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2015 - 06/2008
3	EsketamineIBA 04/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2020
3	Phosphotransferases (Kinase)IBA 01/2020 - 03/2010
3	LigandsIBA 01/2020 - 10/2014
3	Serotonin (5 Hydroxytryptamine)IBA 11/2017 - 06/2008
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2010 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2020
2	PlatinumIBA 05/2020 - 04/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 10/2014
2	ParvalbuminsIBA 01/2019 - 01/2015
2	brexpiprazoleIBA 11/2017 - 09/2014
2	Glutamic Acid (Glutamate)FDA Link 01/2015 - 01/2011
2	CholesterolIBA 01/2015 - 01/2004
2	AntioxidantsIBA 08/2012 - 01/2009
2	Lipoproteins (Lipoprotein)IBA 12/2007 - 01/2004
2	Triglycerides (Triacylglycerol)IBA 01/2004 - 01/2003
1	Poly I-CIBA 06/2022
1	AutoantigensIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	CopperIBA 12/2021
1	Trace Elements (Biometals)IBA 12/2021
1	Dextran SulfateIBA 04/2021
1	Imiquimod (Aldara)FDA LinkGeneric 01/2021
1	Opioid Analgesics (Opioids)IBA 12/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2020
1	16S Ribosomal RNAIBA 08/2020
1	ParaffinIBA 05/2020
1	Dynamins (Dynamin)IBA 05/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 05/2020
1	Focal Adhesion Kinase 1IBA 01/2020
1	PlectinIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	HerbicidesIBA 01/2020
1	Denosumab FDA Link 01/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	Glyphosate (Roundup)IBA 01/2020
1	Betaine (C.B.B.)FDA Link 07/2019
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 01/2019
1	CannabinoidsIBA 01/2019
1	trkB ReceptorIBA 01/2019
1	Nasal SpraysIBA 01/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019
1	IgA receptor (protein B)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2018
1	glucoraphaninIBA 01/2018

Therapy/Procedure

4	Therapeutics 11/2017 - 02/2014
2	Adjuvant Chemotherapy 05/2020 - 04/2016
1	Bite Force (Occlusal Forces) 10/2021
1	Transcranial Magnetic Stimulation 01/2020